Sanofi India launches new product in headache segment
Healthcare service provider Sanofi India, is aiming at a four per cent market share in the headache segment currently valued at Rs 233 crore
“Today’s hectic and stressful lifestyles are impacting the quality of life and productivity of people. Data suggests that over 70% of men and women experience an episode of headache every month, and 36% suffer from it weekly”, said Anindya Chowdhury, Senior Director- Consumer Healthcare, Sanofi India
Caffeine has been shown to have a synergistic and well documented adjuvant action when combined with (painkillers). Research shows that adding caffeine to an analgesic for e.g. paracetamol, increases the potency of the analgesic by approximately 40%5, sanofi said in a press release.
The Economic Times News App for Quarterly Results, Latest News in ITR, Business, Share Market, Live Sensex News & More.